375
Participants
Start Date
November 30, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2028
AADvac1
Subcutaneous injection of AADvac1
Anti-amyloid Monoclonal Antibody (mAb)
Active comparator: intravenous infusion of an anti-amyloid mAb
Collaborators (2)
Axon Neuroscience SE
INDUSTRY
University of California, San Francisco
OTHER
Massachusetts General Hospital
OTHER
Alzheimer's Therapeutic Research Institute
OTHER
Alzheimer's Clinical Trials Consortium
OTHER
National Institute on Aging (NIA)
NIH
Paul S. Aisen
OTHER